PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

PAR cannot sustain this on their own...they need to partner up...

  1. 236 Posts.
    lightbulb Created with Sketch. 29
    PAR cannot sustain this on their own...they need to partner up and then there will be much more confidence to buy in ...Zilosul has promise...sure....but don't forget that a product is only as good as the company that controls it....and If there are financial weaknesses, poor management and instability...zilosul itself could be the victim...who knows ????
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.